SCHEMBL25010255

SCHEMBL25010255

CS(=O)(=O)c1[nH]c(-c2ccccc2)nc1S(=O)(=O)c1ccc(F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
HTT P42858 2/20 0.48
TSHR P16473 2/20 0.48
HSD17B10 Q99714 2/20 0.48
NPBWR1 P48145 1/20 0.47
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
SCD O00767 2/20 0.45
MAPK14 Q16539 2/20 0.44
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALOX5 P09917 1/20 0.44
CSNK1A1 P48729 1/20 0.44
CSNK1D P48730 1/20 0.44
CSNK1E P49674 1/20 0.44
MAPK11 Q15759 1/20 0.44
CSNK1A1L Q8N752 1/20 0.44
THRB P10828 1/20 0.44
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25009200 0.86 MAPT (0.52) LMNAHTTTSHRHSD17B10NPBWR1
SCHEMBL23416222 0.81 LMNA (0.41) LMNAHTTTSHRHSD17B10MAPT
SCHEMBL23416223 0.77 LMNA (0.44) LMNAHTTTSHRHSD17B10NPBWR1
SCHEMBL25009642 0.77 TP53 (0.43) LMNAHTTTSHRHSD17B10MAPT
SCHEMBL25009382 0.75 TSHR (0.42) LMNAHTTTSHRHSD17B10MAPT
SCHEMBL25011148 0.73 LMNA (0.40) LMNAHTTTSHRHSD17B10MAPT
SCHEMBL25009655 0.72 PIN1 (0.46) MAPK14SMN1; SMN2CYP1A2CYP2C9
SCHEMBL25009168 0.71 MAPT (0.39) LMNAHTTTSHRHSD17B10MAPT
SCHEMBL25009379 0.71 LMNA (0.39) LMNAHTTTSHRHSD17B10MAPT
SCHEMBL7184765 0.71 HPGD (0.47) LMNAHTTHSD17B10NPBWR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230041576-A1 METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230041576-A1 METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY NFKBIA, IKBKB, NFKB2 LMNA 487/4885HTT 2142/4885TSHR 4634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.